|
Connect, Learn, Advance Stay ahead on regulatory trends, operational industry insights, and the latest innovations in study startup technology. Breakfast will be provided at 8:30 am. Discussions will run from 9:00 am to noon. Lunch will be provided from noon to 1:00 pm. |
|
Speakers
 |
|
 |
|
 |
|
 |
|
|
|
|
|
|||
|
Christine Senn, PhD, SVP
Site-Sponsor Innovation, Advarra |
|
Kristen Jackson
Study Start-Up Country Head-US
Novartis |
|
Donna Kostandy
Director of Strategic Site
Collaborations, Project Delivery, and the Operations Strategy Unit, PPD Clinical Research Service
|
|
Catee Mullen
Senior Director, Clinical
Research Operations, Duke University School of Medicine |
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
 |
|
|
|
||||||
| Mark J. King VP of Research & Innovation, Corporate Research, Novant Health |
Ashley Davidson VP Product Lead, Advarra |
Kris MacDermant SVP Partnerships and Sites & Institutions, Advarra |
Kate Yawman Director, Product Management, Advarra |
Here's what you can expect:
- Panel discussion on current challenges impacting collaboration between sites, sponsors, and CROs
- Best practices for improving operational efficiency from an IRB and study startup perspective
- Clarity on next steps for sponsors and CROs for the upcoming FDA sIRB mandate
- How to leverage technology to achieve study startup milestones in a timely and compliant manner